Understanding and treating patients with alcoholic cirrhosis: An update

Keyphrases

• Alcoholic Cirrhosis 100%
• Cirrhosis 60%
• Alcoholic Liver Disease 60%
• Alcohol Dependence 40%
• Alcohol Abstinence 40%
• Patient Management 20%
• Oxidative Stress 20%
• Alcohol 20%
• Pathogenic Mechanism 20%
• Abstinence 20%
• Pharmacological Treatment 20%
• Abusers 20%
• Developing Countries 20%
• Immune Response 20%
• Obesity 20%
• Cause of Death 20%
• Fibrosis 20%
• Inflammatory Response 20%
• Diabetes 20%
• Corticosteroids 20%
• Multimodal Approach 20%
• Terminal Stage 20%
• Clinical Management 20%
• Alcohol Consumption 20%
• Nutritional Support 20%
• Alcohol-induced 20%
• Baclofen 20%
• Discriminant Factor 20%
• Anti-tumor Necrosis Factor Antibody 20%
• Ambulatory Patients 20%
• Chronic HCV Infection 20%
• Adipokine Secretion 20%
• Alcohol Relapse 20%
• Oxidative Alterations 20%
• Pentoxifylline 20%
• Severe Alcoholic Hepatitis 20%
• Support Use 20%
• S-adenosylmethionine 20%
• Cirrhosis Mortality 20%

Medicine and Dentistry

• Alcohol Liver Cirrhosis 100%
• Liver Cirrhosis 80%
• Alcohol Liver Disease 80%
• Alcoholic Polyneuropathy 40%
• Alcohol Abstinence 40%
• Serositis 20%
• Infection 20%
• Oxidative Stress 20%
• Secretion (Process) 20%
• Immune Response 20%
• Diabetes 20%
• Fibrosis 20%
• Alcohol Consumption 20%
• Contraindication 20%
• Abstinence 20%
• Clinical Management 20%
• Nutritional Support 20%
• Adipocytokine 20%
• Tumor Necrosis Factor Antibody 20%
• S-Adenosyl Methionine 20%
• Baclofen 20%
• Pentoxifylline 20%
• Pharmacological Treatment 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Alcohol Liver Cirrhosis 100%
• Liver Cirrhosis 80%
• Alcohol Liver Disease 80%
• Infection 20%
• Fibrosis 20%
• Adipocytokine 20%
• Tumor Necrosis Factor Antibody 20%
• S-Adenosyl Methionine 20%
• Pentoxifylline 20%
• Baclofen 20%